| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |